Solstein Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$70K Hold
148
0.03% 202
2025
Q4
$69.1K Hold
148
0.03% 189
2025
Q3
$63.1K Sell
148
-23
-13% -$8.91K 0.01% 188
2025
Q2
$65.5K Buy
171
+91
+114% +$32.8K 0.03% 177
2025
Q1
$27.6K Hold
80
0.02% 179
2024
Q4
$24K Hold
80
0.01% 189
2024
Q3
$32.5K Hold
80
0.02% 174
2024
Q2
$25.7K Hold
80
0.02% 178
2024
Q1
$26.7K Hold
80
0.02% 177
2023
Q4
$21.7K Hold
80
0.02% 179
2023
Q3
$19.7K Hold
80
0.02% 182
2023
Q2
$24.3K Buy
+80
New +$22.2K 0.02% 171
2020
Q3
Sell
-400
Closed -$38K 211
2020
Q2
$38K Hold
400
0.09% 127
2020
Q1
$36K Buy
+400
New +$51.8K 0.14% 96

Other funds holding HCA

Solstein Capital's HCA Position: Q1 2026 in Review

Solstein Capital held its HCA Healthcare (HCA) position steady in Q1 2026 at 148 shares worth $70K. The position accounts for 0.03% of the portfolio, ranked #202.

Solstein Capital first reported a position in HCA in Q1 2020 and has held it in 14 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Solstein Capital held 148 shares of HCA Healthcare worth $70K as of Q1 2026.
  • Solstein Capital left its HCA Healthcare share count unchanged in Q1 2026.
  • HCA Healthcare made up 0.03% of Solstein Capital's portfolio in Q1 2026, its #202 holding.
  • Solstein Capital first reported a position in HCA Healthcare in Q1 2020 and has held it in 14 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Solstein Capital's 13F filing for Q1 2026, filed 14 May 2026.